Gender Detection
Analytes of Interest
Cannabis ChemLab employs advanced genetic testing technologies, such as those developed by Medicinal Genomics, alongside instruments like the Aria Mx qPCR (quantitative Polymerase Chain Reaction) system to accurately determine the gender of cannabis plants early in their growth cycle.
This process involves several key steps and offers significant advantages to cannabis growers:
​
Detection Process:
​
1. Sample Collection: Small samples of plant tissue are collected from young cannabis plants.
2. DNA Extraction: DNA is extracted from the collected tissue samples.
3. PCR Amplification: Specific regions of the extracted DNA that determine gender are targeted and amplified using the Aria Mx qPCR system. This system is capable of detecting and quantifying even minute amounts of DNA, making it highly sensitive and accurate.
4. Analysis: The Aria Mx qPCR analyzes the amplified DNA sequences to identify whether the sequences characteristic of male or female plants are present.
Benefits for Cannabis Growers:
​
Space Optimization: By identifying the gender of cannabis plants early, growers can remove male plants from their growing areas before they mature. This prevents males from occupying valuable space that could otherwise be used for female plants, which are the primary producers of buds.
Preventing Contamination: Male cannabis plants produce pollen, which can fertilize female plants, leading to seeded buds if they are not detected and removed timely. Seeded buds are generally less desirable for consumers and can significantly reduce the quality and market value of the harvest. Early detection and removal of male plants prevent this cross-pollination.
​
Increased Efficiency: Using genetic testing to determine plant gender early in the growth cycle reduces labor and resources spent nurturing plants that will ultimately not contribute to the final yield. Growers can focus their efforts and inputs on female plants, ensuring better resource allocation and improving overall efficiency.
​
Early Planning and Management: Knowing the plant's gender early allows for more precise cultivation strategies, such as optimizing plant spacing and nutrient applications tailored specifically to female plants, enhancing overall yield and quality.
​
By integrating Medicinal Genomics' technology with the Aria Mx qPCR system, Cannabis ChemLab provides a crucial service that helps cannabis growers maximize their growing space, prevent unwanted pollination, and increase the efficiency of their operations, leading to higher quality and more profitable harvests.
Gender Detection
Male Eradication
Male cannabis plants are usually unwanted in flower-focused grows because they pollinate females, leading to seeded buds which are less potent and valuable. Removing males ensures higher quality, seedless cannabis flowers.
Analyte of Interest
The Medicinal Genomics assay employs a sophisticated genetic testing method to determine the sex of cannabis plants, differentiating between male and female seeds, seedlings, and mature plants. This is achieved by detecting specific genetic markers associated with the Y chromosome, present only in male cannabis plants.
​
Benefits to Cannabis Growers:
​
- Early Sex Determination: This genetic testing allows growers to determine the sex of their plants at a very early stage, even before they start showing physical sex traits. This is especially useful in cannabis cultivation, where male plants are often undesirable in the growing area because they can pollinate females, leading to seeded flowers.
​
- Resource Optimization: By identifying male plants early, growers can remove them from their cultivation areas before they reach maturity. This saves resources such as space, nutrients, and lighting, which can then be redirected to nurturing female plants that produce the valuable buds.
​
- Improved Yield Quality: Eliminating male plants before they pollinate females ensures that the female plants remain unfertilized. Unfertilized female plants produce higher-quality buds, which are more potent and have a greater market value.
​
The Medicinal Genomics assay provides a precise, efficient, and timely tool for sex determination in cannabis plants, significantly enhancing the management and outcomes of cannabis cultivation.